Bladder Carcinoma Samples

In this category we offer human serum samples from donors with Malignant neoplasm of the Lateral wall and the Overlapping lesion of bladder. For normal control groups please switch to the category Healthy Donors. Please open the detailed product description for further information. If you do not find the research samples you are looking for, please contact us.

Available filters
-
83 Products

Human Serum - C68.0

Donor:
Gender: Female Age: 87
Diagnosed disease:
C68.0 - Malignant neoplasm of urethra
Parameter:
Anti-Glutamate Decarboxylase (GAD) Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Donor:
Gender:
Female
Age:
87 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of urethra [C68.0]
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Glutamate Decarboxylase (GAD)
Qual: negative
Quant: < 5.00 IU/mL
Source: this donation
< 10.00 IU/mL
Method: EIA (Enzyme Immuno Assay)
System: Euroimmun Analyzer EUROIMMUN AG
Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 10.00 IU/mL
Method: EIA (Enzyme Immuno Assay)
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH296959
1 mL (€50.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Prostate specific antigen (PSA), total - C67.8

Donor:
Gender: Male Age: 77
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
77 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: positive
Quant: 10.83 ng/mL
Source: this donation
< 4.4 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275646
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C67.8

Donor:
Gender: Male Age: 71
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
71 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: negative
Quant: 1.51 ng/mL
Source: this donation
< 4.4 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167268
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C67.8

Donor:
Gender: Male Age: 74
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
74 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: negative
Quant: 0.34 ng/mL
Source: this donation
< 4.4 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167273
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C67.8

Donor:
Gender: Male Age: 78
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
78 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: negative
Quant: 0.85 ng/mL
Source: this donation
< 4.4 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167276
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C67.8

Donor:
Gender: Male Age: 64
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
64 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: negative
Quant: 1.92 ng/mL
Source: this donation
< 4.4 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167278
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Lactate dehydrogenase (LDH) - C67.8

Donor:
Gender: Female Age: 53
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Lactate dehydrogenase (LDH)
Donor:
Gender:
Female
Age:
53 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Lactate dehydrogenase (LDH)
Qual: positive
Quant: 5.37 µmol/s/L
Source: this donation
< 4.16 µmol/s/L
Method: Photometry
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167207
0.5 mL (€81.25)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C67.8

Donor:
Gender: Male Age: 81
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
81 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: negative
Quant: 1.42 ng/mL
Source: this donation
< 4.4 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167259
0.6 mL (€97.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - C67.2

Donor:
Gender: Male Age: 70
Diagnosed disease:
C67.2 - Malignant neoplasm of lateral wall of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
70 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Details:
centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
  • Malignant neoplasm of lateral wall of bladder [C67.2]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: negative
Quant: 3.78 ng/mL
Source: this donation
< 4.4 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH78739
1 mL (€162.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Citrate plasma - D-Dimer - C67.8

Donor:
Gender: Male Age: 79
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
D-Dimer
Donor:
Gender:
Male
Age:
79 Years
Sample:
Matrix:
Citrate plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
D-Dimer
Qual: positive
Quant: 6.04 mg/l FEU
Source: this donation
< 0.49 mg/l FEU
Method: Turbidimetry
System: STA-R Evolution Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH176402
1.3 mL (€32.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 72
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
72 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 0.56 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH94783
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 76
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
76 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 0.57 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156318
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 78
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
78 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.94 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156097
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 61
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
61 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.75 ng/mL
Source: this donation
< 0.5 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH163769
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 73
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
73 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.57 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH182970
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - C67.1

Donor:
Gender: Male Age: 82
Diagnosed disease:
C67.1 - Malignant neoplasm of dome of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
82 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of dome of bladder [C67.1]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: negative
Quant: 0.55 ng/mL
Source: this donation
< 0.60 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: Kryptor Thermo Fisher (Brahms)
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107474
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - C67.1

Donor:
Gender: Male Age: 82
Diagnosed disease:
C67.1 - Malignant neoplasm of dome of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
82 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of dome of bladder [C67.1]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: negative
Quant: 0.58 ng/mL
Source: this donation
< 0.60 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: Kryptor Thermo Fisher (Brahms)
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107439
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 67
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
67 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1 ng/mL
Source: this donation
< 0.60 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: Kryptor Thermo Fisher (Brahms)
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107935
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.2

Donor:
Gender: Female Age: 84
Diagnosed disease:
C67.2 - Malignant neoplasm of lateral wall of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Female
Age:
84 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of lateral wall of bladder [C67.2]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 0.69 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH233572
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Female Age: 83
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Female
Age:
83 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 0.73 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH233525
0.9 mL (€33.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human EDTA plasma - Prostate specific antigen (PSA), total - C67.8

Donor:
Gender: Male Age: 66
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
66 Years
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: positive
Quant: 8.19 ng/mL
Source: this donation
< 4.40 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156376
0.5 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human EDTA plasma - Prostate specific antigen (PSA), total - C67.2

Donor:
Gender: Male Age: 72
Diagnosed disease:
C67.2 - Malignant neoplasm of lateral wall of bladder
Parameter:
Prostate specific antigen (PSA), total
Donor:
Gender:
Male
Age:
72 Years
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of lateral wall of bladder [C67.2]
Parameter Result Ref. / Cut-Off Measuring Information
Prostate specific antigen (PSA), total
Qual: positive
Quant: 8.15 ng/mL
Source: this donation
< 4.40 ng/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: cobas Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156392
0.5 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 61
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
61 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.26 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294846
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 61
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
61 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.19 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294856
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 61
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
61 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.25 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294851
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Female Age: 72
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Female
Age:
72 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.89 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294901
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Female Age: 72
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Female
Age:
72 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.03 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294904
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Male Age: 71
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Male
Age:
71 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.04 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294732
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Female Age: 69
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Female
Age:
69 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 0.55 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294852
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Procalcitonin (PCT) - C67.8

Donor:
Gender: Female Age: 78
Diagnosed disease:
C67.8 - Malignant neoplasm of overlapping lesion of bladder
Parameter:
Procalcitonin (PCT)
Donor:
Gender:
Female
Age:
78 Years
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of bladder [C67.8]
Parameter Result Ref. / Cut-Off Measuring Information
Procalcitonin (PCT)
Qual: positive
Quant: 1.11 ng/mL
Source: this donation
< 0.50 ng/mL
Method: EIA (Enzyme Immuno Assay)
System: cobas 8000 Roche
Measured in: serum
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294712
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)
  • <
  • 1